Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective drugs and biomarkers in HCC therapy are still scarce. The present study was designed to investigate dysregulated pathways, novel biomarkers and therapeutic targets for HCC. The gene expression dataset of GSE14520, which included 362 tumor and their paired non-tumor tissues of HCC, was extracted for processing by the Robust multi-array average (RMA) algorithm in the R environment. SAM methods were leveraged to identify differentially expressed genes (DEGs). Functional analysis of DEGs was performed using DAVID. The GeneMania and Cytohubba were used to construct the PPI network. To avoid individual bias, GSEA and survival analysis were employed to v...
A very low 5-year survival rate among hepatocelluHar carcinoma (HCC) patients is mainly due to lack ...
International audienceHepatocellular carcinoma (HCC) represents one of the most frequently diagnosed...
Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis. Currently, only sorafen...
<p>Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective dr...
<p>Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective dr...
Objective Hepatocellular carcinoma (HCC) is a common cancer with a high mortality rate; the molecula...
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. Howe...
Hepatocellular carcinoma (HCC) is one of the major causes of cancer deaths worldwide. New diagnostic...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. T...
Hepatocellular carcinoma (HCC) is a devastating disease worldwide. Though many efforts have been mad...
Objective: Various treatments have greatly reduced the mortality of hepatocellular carcinoma (HCC). ...
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Conventional diagnosi...
Objective. To evaluate the association between upregulated differentially expressed genes (DEGs) and...
A very low 5-year survival rate among hepatocelluHar carcinoma (HCC) patients is mainly due to lack ...
International audienceHepatocellular carcinoma (HCC) represents one of the most frequently diagnosed...
Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis. Currently, only sorafen...
<p>Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective dr...
<p>Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective dr...
Objective Hepatocellular carcinoma (HCC) is a common cancer with a high mortality rate; the molecula...
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. Howe...
Hepatocellular carcinoma (HCC) is one of the major causes of cancer deaths worldwide. New diagnostic...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. T...
Hepatocellular carcinoma (HCC) is a devastating disease worldwide. Though many efforts have been mad...
Objective: Various treatments have greatly reduced the mortality of hepatocellular carcinoma (HCC). ...
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Conventional diagnosi...
Objective. To evaluate the association between upregulated differentially expressed genes (DEGs) and...
A very low 5-year survival rate among hepatocelluHar carcinoma (HCC) patients is mainly due to lack ...
International audienceHepatocellular carcinoma (HCC) represents one of the most frequently diagnosed...
Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis. Currently, only sorafen...